Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022 at 12:15 PM EDT
A Conshohocken firm received approval for a cancer therapy from the European Commission.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |